Coyne Terrance P. (CIK 1814876) reported 41 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-17). Recent activity: Sell RPRX (9,230 shares), Sell RPRX (1,772 shares), Buy RPRX (11,002 shares), Sell RPRX (64,399 shares), Buy RPRX (24,263 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 9,230 | $540,752 |
| 2026-08-17 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 1,772 | $104,799 |
| 2026-08-07 | Royalty Pharma plc (RPRX) | EVP & CFO | Buy | 11,002 | $0 |
| 2026-05-28 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 64,399 | $3.5M |
| 2026-05-08 | Royalty Pharma plc (RPRX) | EVP & CFO | Buy | 24,263 | $0 |
| 2026-04-30 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 32,916 | $1.6M |
| 2026-04-30 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 1,875 | $93,334 |
| 2026-04-02 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 1,875 | $90,622 |
| 2026-04-02 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 32,916 | $1.6M |
| 2026-03-25 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 32,916 | $1.5M |
| 2026-03-25 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 1,875 | $85,369 |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 10,429 | $490,267 |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 22,487 | $1.0M |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 1,292 | $60,298 |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 583 | $27,407 |
| 2026-02-25 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 32,916 | $1.5M |
| 2026-02-25 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 1,875 | $84,975 |
| 2026-02-13 | Royalty Pharma plc (RPRX) | EVP & CFO | Buy | 26,626 | $0 |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 102,581 | $4.3M |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 108,759 | $4.7M |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 19,076 | $825,800 |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 5,843 | $245,873 |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 6,195 | $265,394 |
| 2026-02-04 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 1,087 | $47,056 |
| 2026-01-23 | Royalty Pharma plc (RPRX) | EVP & CFO | Sell | 65,832 | $2.6M |
Source: SEC Form 4 filings · as of 2026-08-17